Coherus Oncology, Inc.CHRSNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
+0.2%/yr
Annual compound
5Y CAGR
-6.1%/yr
Recent acceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 67.24% | +20.2% |
| 2024 | 55.97% | +46.5% |
| 2023 | 38.19% | -42.8% |
| 2022 | 66.79% | -18.9% |
| 2021 | 82.36% | -10.6% |
| 2020 | 92.08% | -3.3% |
| 2019 | 95.20% | +188.2% |
| 2018 | -107.90% | +98.9% |
| 2017 | -10216.90% | -30090.8% |
| 2016 | -33.84% | - |